Negi Sandeep, Sahu Jitendra Kumar, Bhatia Prateek, Kaur Anupriya, Malhi Prahbhjot, Singh Gagandeep, Arora Amit, Sankhyan Naveen, Kharbanda Parampreet S
Pediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Molecular Hematology Laboratory, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Lancet Reg Health Southeast Asia. 2022 Nov 16;8:100094. doi: 10.1016/j.lansea.2022.100094. eCollection 2023 Jan.
Diphtheria, Tetanus, and whole-cell Pertussis (DTwP) vaccination-associated seizures form the commonest type of serious adverse event following immunization in India and are an important reason for vaccine hesitancy. Our study explored the genetic explanation of DTwP vaccination-associated seizures or subsequent epilepsies.
Between March 2017 and March 2019, we screened 67 children with DTwP vaccination-associated seizures or subsequent epilepsies, and of those, we studied 54 without prior seizures or neurodevelopmental deficits. Our study design was cross-sectional with a 1-year follow-up having both retrospective and prospective cases. We performed clinical exome sequencing focused on 157 epilepsy-associated genes and multiplex ligation-dependent probe amplification of the gene at enrolment. We applied the Vineland Social Maturity Scale for neurodevelopmental assessment at follow-up.
Of 54 children enrolled and underwent genetic testing (median age 37.5 months, interquartile range 7.7-67.2; diagnosis at enrolment: epilepsy 29, febrile seizure 21, and febrile seizure-plus 4), we found 33 pathogenic variants of 12 genes. Of 33 variants, 13 (39%) were novel. Most pathogenic variants were found in gene (n = 21/33; 64%), in 2 children, and 10 children had one variant in , , , , , , , , , and . Five or more seizures (odds ratio [OR] = 5.3, confidence interval [CI]: 1.6-18.4, p = 0.006), drug-resistant epilepsy (OR = 9.8, 95% CI: 2.6-30.7, p = 0.001) and neurodevelopmental impairment (social quotient < 70) (OR = 5.6, 95% CI: 1.65-17.6, p = 0.006) were significant predictors of genetic diagnosis.
Our study provides proof-of-concept for genetic aetiology in children with DTwP vaccination-associated seizures or subsequent epilepsies and has important implications for vaccination policies in developing countries.
International Pediatric Association Foundation, Inc. (IPAF): İhsan Doğramaci research award 2016/2017; Indian Council of Medical Research (ICMR), New Delhi, India: No.3/1/3/JRF-2016/HRD/LS/71/10940.
白喉、破伤风和全细胞百日咳(DTwP)疫苗接种相关惊厥是印度免疫接种后最常见的严重不良事件类型,也是疫苗犹豫的重要原因。我们的研究探讨了DTwP疫苗接种相关惊厥或后续癫痫的遗传学解释。
2017年3月至2019年3月期间,我们筛查了67例患有DTwP疫苗接种相关惊厥或后续癫痫的儿童,其中我们研究了54例既往无惊厥或神经发育缺陷的儿童。我们的研究设计为横断面研究,随访1年,包括回顾性和前瞻性病例。我们进行了聚焦于157个癫痫相关基因的临床外显子测序,并在入组时对该基因进行多重连接依赖探针扩增。我们在随访时应用文兰社会成熟量表进行神经发育评估。
在54例入组并接受基因检测的儿童中(中位年龄37.5个月,四分位间距7.7 - 67.2;入组时诊断:癫痫29例,热性惊厥21例,热性惊厥加复杂型4例),我们发现了12个基因的33个致病变异。在33个变异中,13个(39%)是新发现的。大多数致病变异存在于基因中(n = 21/33;64%),2例儿童存在于基因中,10例儿童在基因、基因、基因、基因、基因、基因、基因、基因、基因和基因中有一个变异。发作5次或更多次(比值比[OR] = 5.3,置信区间[CI]:1.6 - 18.4,p = 0.006)、耐药性癫痫(OR = 9.8,95% CI:2.6 - 30.7,p = 0.001)和神经发育障碍(社会商数 < 70)(OR = 5.6,95% CI:1.65 - 17.6,p = 0.006)是基因诊断的显著预测因素。
我们的研究为DTwP疫苗接种相关惊厥或后续癫痫儿童的遗传病因提供了概念验证,对发展中国家的疫苗接种政策具有重要意义。
国际儿科学会基金会(IPAF):2016/2017年伊桑·多格拉马西研究奖;印度医学研究理事会(ICMR),印度新德里:编号3/1/3/JRF - 2016/HRD/LS/71/10940。